David Jin
2023 - Fortress Biotech
In 2023, David Jin earned a total compensation of $1.3M as Chief Financial Officer and Head of Corporate Development at Fortress Biotech, a 15% decrease compared to previous year.
Compensation breakdown
Option Awards | $582,500 |
---|---|
Salary | $400,000 |
Stock Awards | $330,400 |
Other | $7,333 |
Total | $1,320,233 |
Jin received $582.5K in option awards, accounting for 44% of the total pay in 2023.
Jin also received $400K in salary, $330.4K in stock awards and $7.3K in other compensation.
Rankings
In 2023, David Jin's compensation ranked 903rd out of 2,910 executives tracked by ExecPay. In other words, Jin earned more than 69.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 903 | 69th |
Manufacturing | 534 | 67th |
Chemicals And Allied Products | 361 | 60th |
Drugs | 350 | 60th |
Pharmaceutical Preparations | 239 | 62nd |
Jin's colleagues
We found two more compensation records of executives who worked with David Jin at Fortress Biotech in 2023.
News
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2023 pay stays at $350K
August 28, 2024
AVENUE THERAPEUTICS CEO Alexandra MacLean's 2023 pay jumps 304% to $1.2M
May 3, 2024
Fortress Biotech CFO David Jin's 2023 pay jumps 267% to $1.3M
April 5, 2024
Avalon GloboCare Corp. CEO David Jin's 2022 pay stays at $360K
September 8, 2023
Avalon GloboCare Corp. CEO David Jin's 2021 pay falls 64% to $360K
November 21, 2022
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2020 pay slips 20% to $1.1M
December 13, 2021
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2019 pay rises 3% to $1.3M
June 22, 2020
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2018 pay jumps 34% to $1.3M
June 17, 2019